...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Looks like the Vancouver account is getting cleaned out

Lots of big drops in the fictious accounts in the last two days....nice to see!

Share
New Message
Please login to post a reply